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Cloning, expression and modulation of a mouse NMf)A receptor subunit 
cm the pb 1 and cktmphyjio~~~l 
pgmth [12\. The KMDA receptor channel hiihly 
penneab?e Coca” play4 pI key rote in syuqNk plasticity. 
thou@t to rmderlii memory and kttming RS well 525 
de%~lapment of the rHzvCw5 system t3.4j. FunhctnlorC 
abnormal activation of NMDA rccqror channels has 
been su&?ewd to tead to neuronal cell death obscrvd 
in various acute and chronic diwrders such as ischcmia. 
stroke. Ahheimer*s dementia and Huntington’s diseax! 
[X6]. 
.k family af rodenr GbR channel subunits has been 
;L-acwizex! bv cloning ani: cspxioa of the cDNA: 
[T- I Ti_ -i-L WI ;;i, X I-GluR4 (or r,;li~Rk+GluRD) sub- 
units (T-9.1 l] and mouse al (GluRl) and a2 (GluR.21 
subunits IlO] are highly homologous with each other 
(-70% aminoacid sequence identities). thusclass%ed as 
the a subfamily of the GluR channel. The members of 
the a subfamily form homomeric and hetcromeric 
channels responsive to L-glutamate. quisqualate. 
AMPA and kainate. The apparent afinities of these 
channels are higher for quisqualate and AMPA than f~br 
A!#uwtiliotu: AMPA. cramin~~h?d~s~-Imclh~i~i~~tc pm 
pionic aci& APV. rt2-amino-5-phosphono~~krate: GluR. glutam.at~ 
mptor. nAChR. nicolinic acetykholinc rcccptor. NMDA. S- 
methyl-waspartate: TPA. 12-O-telrad~noylphorbol I3-acctaw 
Comspo~d,w~~ uddwss: hl. Mishina. Dcpllrtmzcr of N~wpham:!- 
cologv. Brain Research Insthutc. Niigata University. Asahimachi. 
Niigara 951. Japan. Fax: (81) (25) 25 615% 
kuinsrte. indic-ring that :he & su3fmmitp rcptwenm the 
AMPA-&ective GluR channeb Additionrl memhe~ 
of the GluR chanlrel QWly hawe ~XEI i&d&+ hy 
scrccnim un& low Wiqency ccwibns 
of the d: subf&tnily subunits m p;roe& The rat GtuRS 
and GluRb subunito [I GluR6) 
whunit [!G] arc highly herand 
L\IIT classified as the&J subfamt& of the GluR CM 
The 82 (GluR6) subunit forms homome& channels 
responsive to k-gW%mate and kainatc but not to 
RMPA, indicating that the @ subfamily represents he 
kainate-selectiwr GluR channel. The o&et subfamily p 
inch&s the rat KA-1 subunit 113) and the mouse y2 
suhunil 1171. The KA-I subunit expressed in rnam- 
tnalhn celIs exhibits high affinity binding for kainatc. 
The ~2 subunit when expressed tq&er with the @ 
suburtit p&s futwti~nal GluR chinch selecti~ for 
!L:;.wrc. -!-huS the ; rl&ll;r~ ZAG qxcdui~ 2 
k;rinate-sclecttve GiuR channels. 
Further xrwnir& under law anngcncy conditions 
using these GluR subunit cDNAs as probes has re- 
waled the presemx of additional GluR channel sub- 
fanlilies. Here. ux report that one of Wse subunits. 
designated as 0. is found in two forms and cons;titutes 
functional GluR channels with characterink of the 
SMDA receptor channel; the larger form corresponds 
to the tat NMDA receptor subunit NMDAR1[15]. We 
have found that TPA treatmen: positively mochdatcs 
the C1 NMDA receptor channel actib<lty. 
2. MATERIALS AND METHODS 
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Fib ). 1. Alignment of the dcuiuccd amino acid scquunccs ol'thc mouse C;lnK al, al and CI subunits. Numbers ofthc nmino acid r&Juts at I 
right-hand end of the individual lines arc given. Sets of’idcntical amino acid &duos in the homologous region arc cncloscd.Thc 37 amino a 
rwiducs (rcsiducs 846-887) missing in the Cl-2 subunit nw uudcrlincd. The putative tmnsmcmbmnc scgmcnts (MI-M41 arc indicated. 1
awmginc Rsiducs as polcntial N-glycosylation sites itr the pnaiictcd cxtmccllulitr domain wcmarkrd below with nstcrisks. Consensus pho+ 
Q%ttiOa sitcsfoorCaa:‘-calmodulindepcndcnt protein kinusctypcllinthcprcdictc~intra~~l~:llnl~~rJonrainan:markcdwithopencirclcs.Theposi:l: 
of the Point mutations al-K44SE [IY] ar;d c&R586Q 119.20.37] alliicting the ugonist binding and channel propcrtics, tvspcctivcly, are indicar 
by :\rro\vhcads. 
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A 
CilU hp NMDA Olu withoul Qly 
-z-_ CJ- + zh-9 
aspartatc, 100 PM NMDA (Fig. 3A) and 100 ,uM 
quisqualate (not shown) in the prescncc of 6 PM ylycinc 
at ---70 mV mcmbmnc potcntinl. No rcsponsc was dc- 
tcctcd for 100 PM kninatc and IO0 PM AMPA cvcn in 
the ppCse\iCY of &zinc. The n\~pon~c to 10 JIM L-&I- 
tamute wus hardiy dcte&:blc in the ubscncc of g:ycinc. 
au absolutely rcquircd activator of the NMDA rcccptor 
[2334), and was diminished in the pr~mcc of 1%) yM 
n&amino-S-phosphonovalelatc (APV). a specific com- 
pctitive antagonist of the NMDA receptor 1251 (Fig, 
3A). 100 PM Mg2+. known to block the NMDA re- 
captor channel in a voltage-dependent manner [26,27], 
and 1 ,uM (+)-MK-801. a channel blocker of the 
NMDA receptor [25], nxhxed the response to L-glu- 
tamate (Fig, 3A). The Cl channel activity was at- 
tenuated by the presence of 100 JLM Zn’+. reported to 
induce a non-competitive inhibition of the NMDA 
response in voltage-independent manner [29.30] (not 
shown). Similar results were obtained for the <l-2 sub- 
unit. The homomeric (1 channels exhibited a clear in- 
Ward current in Na+- and K’-free Ringer’s olution con- 
taining 20 mM Cal+ (Ca”-Ringer’s sclution [19]), 
whereas a marginal outward current was observed in 
control Na’- and K’-free Ringer’s solutim (Fig. 38). 
A 
TPA After washing 
Olll au Cm 







indicating that the 51 channels arc penne&k to Ca”. 
Spermine. reportni to potentiate the NMDA teceptor 
[3 11, enhanced the response of Ci homomcrk cdtanad 
by I A k 0. I fold (n=6) (Fig. XX This eff&t ws re 
versiblc. These pharmacological and electrophysiologi- 
cal propertics arc in good agnxment with tha of the 
NMDA-type GluR channel [l.Z3I~. 
Ttwrmcnt of the uagtcs with IpA3 WA for i3 min 
cnhnnced the trsponss of the it +annels to IO PM 
L-g!utamatc by Z.? + 0.4 fo!c! (mean ‘1 ?t>J. ti~=IOJtFi~. 
4A). The channel activity decrcused gradually to the 
initial level by washing. This enhancing effect cannot be 
non-spccitic because the TFA tteatint exerted .no 
appreciable ffiit on the current amp!itude of the hete- 
romeric aM2 GluR channels expressed in o&tes (not 
shown). Furthermore. the effixt of TPA %a abolished 
by the simultaneous treatment with 5 J&I! staufo- 
sporine. a protein kinasc inhibitor PI!] (Fig. 4B). En- 
hancing ef&ct of spetmine was obsewd even atIer 
treatment with TPA. The cl-2 channels WZLP similarly 
modulated by TPA treatment and polyaminc. 
4. DISCUSSION 
The present investigation has shown the presence of 
two forms of a mouse NMDA receptor subunits, dc- 
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M2 
nAChR u DIUW (1 
signnted UB {l nnd {l-2. The NMDA rcccptor subunit 
~1 its well 11s its smullcr form cl -2 is sndowcd with most 
of the propcrtics chuructcristic for thr NMDA receptor, 
such 8s nctivution by glycinc, C$’ pcrmettbility, block- 
ing by Mg?‘, inhibition by Zn?* und ectivation by po- 
lyim\inc 11,2,31], in ucword with the rut counterpttrt of 
the (1 subunit [IS]. In the ubscncc of glycinu, I&U- 
tl\mtttc or NMDA ulonc Giled to evoke the rcsponsc of 
the by1 or cl-2 channels, in Lvnsistcnt with the ubsolutc 
rquircmcnt of glgcinc for sctivation of rt\t NMDA 
nxxptor chunncls c.uprcsscd in ,YW~JW oocytes by in- 
jcction of rat bruin poly(A)’ RNA [24]. On the other 
hand. the mt counterpart of the Cl subunit has been 
rcportcd to bc Wivutcd by MNDA in the ubscncc of 
glgcinc [I 51, cdthough possible contnminution of glycinc 
in the nss~~y system used ccm not bc cscluded. The loivcr 
ch:m114 activities of holl~o;ncri< I or cl-2 chiinncls i\s 
compurcd with NMDA channel acti\4tics obscrwd in 
oocytns it~jcxtcd with wwse hroin poly( .Z)‘RNA ma> 
imply the requirement of additions subunits for the 
NMDA nxeptor channel. 
Since the GluR chnnncls of NMDA-type and non- 
NMDA tgpc ~trc structurally similar but i\W flmction- 
ully distinct. it is of interest to prcciscly inspect the 
primary structures of the glutamate-gatcd ion channels. 
Under the nssumption thut the basic structure is similttr 
bctwcn the GluR chnuncl i\ud the nicotinic acctyl- 
choline nwptor (nAChR) channel, one cun figure out 
the putative chant&fomling region of the GluR 
channels (Fig. 5). N~gittivcly-charged aud polar 
residues are found in the 51 subunit at the positions 
corresponding to the four rings of the nAChR chimncl. 
major determinants of the ion flow through tile channel 
[13.34]. Asparagine residue occupies the position corre- 
sponding to glutamine or arginine residue >f the GluR 
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al and a2 subunits, which dctcrmincs the Ca” permca- 
bility of the GluR channel [19,20]. Uriquc to the <I 
subunit is the prcscncc of a contiguous stretch of ncga- 
tivcly-charged aspartutc and gtutumatc rcsiducs at the 
amino-terminal side of the scgmcnt M2. The corm- 
eponding region of the nAChR includes the intcr- 
mcdiutc ring constituting !hs. nurrawc$ const@,tian or 
tho~chunncl, In view of the Ibct thrrt a, point mutFii,on 
introducql into the intermcdiute. ring ST the .nAChR 
chtrnncl dccntiaes not only the csnductanw but-qlso the 
sensitivity to Mg’* [33], the ntrctch of nsmtivcly cho 
uvpbrtute tend glutgmrrtc rcaidues of 
unit may. be responsibla for the 
chunnel block by M$+. On the.61 
boxyl-tcrminul r@on of rregment 
scrvcd umong GluR aubunits and thus may play an 
itnportont role common to the GluR channel family. 
Our finding thut the cl chilnnel activity in enha& 
by TPA tmutmcnt mists an intri$uing poxxibility that 
the NMDA receptor chunnel corn be nzgul~zd by pro- 
tcin kinascs und such modutution might play I role in 
long-term petcntiution, excitotoxity and developmcnt~l 
synaptic pl,lasticity, in which NMDA apton are 
thought to rncdiute key steps [I-J). In this reqxcl, il is 
to be noted thnt potcntilrtion of thr NMDA receptor by 
II g opioid bus been reported to k medintcd by protein 
kinusc C [3S]. Furthermore, protein kinax C has b@zn 
sumsted to mediate the induction nnd mnintenancc @f 
long-term potcntiution [36]. 
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